Form 4: ACHV CEO Earns Performance-Based Stock Units

ACHIEVE LIFE SCIENCES CEO Richard Stewart earned 297,500 performance-based restricted stock units after the company met specific performance criteria.

Summary

• Richard Stewart, CEO and Director of ACHIEVE LIFE SCIENCES, INC. (ACHV), acquired 297,500 Performance Restricted Stock Units (PRSUs) on September 4, 2025.
• These PRSUs were earned upon the achievement of specific performance criteria, as certified by the Compensation Committee of the Issuer's Board of Directors.
• The first tranche of 140,000 PRSUs, previously reported on January 24, 2024, has an expiration date of January 22, 2028.
• The second tranche of 157,500 PRSUs, previously reported on January 14, 2025, has an expiration date of January 13, 2029.
• Each PRSU represents a contingent right to receive one share of ACHV common stock at settlement.
• The total number of shares underlying the PRSUs vest upon the achievement of certain milestones.

Sentiment

Score: 8

Explanation: The earning of a significant number of performance-based restricted stock units by the CEO indicates that the company has met specific, pre-defined performance criteria, which is a strong positive signal for operational execution and goal achievement. This aligns management incentives with shareholder value.

Positives

• CEO Richard Stewart earned 297,500 Performance Restricted Stock Units (PRSUs), indicating the achievement of specific company performance criteria.
• The Compensation Committee certified the achievement of these performance criteria, suggesting strong corporate governance and alignment with shareholder interests.
• The earning of these units demonstrates management's successful execution against pre-defined goals.

Future Outlook

The vesting of the earned Performance Restricted Stock Units is contingent upon the achievement of certain future milestones, aligning executive compensation with long-term company performance.

Management Comments

• The Compensation Committee of the Issuer's Board of Directors certified the achievement of certain performance criteria.

Industry Context

The awarding of performance-based equity to executive leadership is a common practice in the biotechnology and pharmaceutical sectors, aiming to incentivize management to achieve strategic milestones, such as clinical trial progress or regulatory approvals, which are critical value drivers in these industries.

Comparison to Industry Standards

• Performance-based restricted stock units are a standard form of executive compensation in the life sciences industry, aligning management incentives with shareholder value creation, similar to practices at companies like Amgen or Gilead Sciences.
• The certification of performance criteria by an independent Compensation Committee is a best practice in corporate governance, ensuring objectivity in executive reward structures, consistent with leading public companies.

Corporate Governance

Stakeholder Impact

• Shareholders: Positive, as the achievement of performance criteria suggests successful company operations and aligns executive incentives with shareholder interests.
• Employees: May signal a positive outlook for the company's performance and stability.
• Management: Direct financial benefit and recognition for achieving performance goals.

Next Steps

• The PRSUs will vest upon the achievement of certain milestones.
• The shares underlying the PRSUs will be settled at a future date.

Key Dates

Recommendation

The earning of performance-based restricted stock units by the CEO is a positive indicator that the company has met its internal performance targets, reflecting successful operational execution. This aligns management's interests with long-term shareholder value. However, this filing primarily reports compensation rather than an open market purchase, so while it's a good sign, it doesn't fundamentally change the investment thesis to warrant an immediate 'buy' or 'strong buy' recommendation based solely on this information. It reinforces a 'hold' position for existing investors and suggests continued monitoring for potential investors.

Keywords

ACHIEVE LIFE SCIENCES, ACHV, Richard Stewart, Performance Restricted Stock Units, PRSUs, Insider Transaction, CEO Compensation, Stock Award, Equity Compensation